3555 Stock Overview
iROC Co., Ltd. engages in the research and development, and sale of natural products in Japan.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
iROC Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$35.70 |
52 Week High | NT$41.00 |
52 Week Low | NT$22.70 |
Beta | 0.36 |
1 Month Change | 54.55% |
3 Month Change | 5.31% |
1 Year Change | 30.29% |
3 Year Change | -18.13% |
5 Year Change | -1.25% |
Change since IPO | -97.83% |
Recent News & Updates
Shareholder Returns
3555 | TW Semiconductor | TW Market | |
---|---|---|---|
7D | 7.2% | -2.8% | -0.6% |
1Y | 30.3% | 49.3% | 29.2% |
Return vs Industry: 3555 underperformed the TW Semiconductor industry which returned 49.3% over the past year.
Return vs Market: 3555 exceeded the TW Market which returned 29.2% over the past year.
Price Volatility
3555 volatility | |
---|---|
3555 Average Weekly Movement | 10.9% |
Semiconductor Industry Average Movement | 5.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 3555's share price has been volatile over the past 3 months.
Volatility Over Time: 3555's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | n/a | n/a | www.iroc.com.tw |
iROC Co., Ltd. engages in the research and development, and sale of natural products in Japan. The company offers drinking water under the VACHI; skin care products under the QINGSKIN; and chicken essence under the DDDrops brand names, as well as DEDrops ginseng tonic drinks. It serves customers through online shops and distributors.
iROC Co., Ltd. Fundamentals Summary
3555 fundamental statistics | |
---|---|
Market cap | NT$919.73m |
Earnings (TTM) | -NT$18.33m |
Revenue (TTM) | NT$65.41m |
14.1x
P/S Ratio-50.2x
P/E RatioIs 3555 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3555 income statement (TTM) | |
---|---|
Revenue | NT$65.41m |
Cost of Revenue | NT$50.14m |
Gross Profit | NT$15.28m |
Other Expenses | NT$33.61m |
Earnings | -NT$18.33m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.71 |
Gross Margin | 23.36% |
Net Profit Margin | -28.02% |
Debt/Equity Ratio | 90.9% |
How did 3555 perform over the long term?
See historical performance and comparison